Literature DB >> 6841187

Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: a comparative study with a low-dose rate system.

Y Shigematsu, K Nishiyama, N Masaki, T Inoue, Y Miyata, H Ikeda, S Ozeki, Y Kawamura, K Kurachi.   

Abstract

From September, 1974 through December, 1979, a total of 249 patients with carcinoma of the cervix uteri Stage IIb and III were randomly allocated to either remotely controlled high-dose-rate intracavitary radiotherapy or manual afterloading low-dose-rate therapy, with radiotherapy of 20 Gy in 2 weeks to Point A to whole pelvis and 40 Gy in 4 weeks to the parametria. The dose to Point A by intracavitary radiotherapy was 40-60 Gy with one or two fractions in the low-dose-rate group and 30 Gy for the high-dose-rate group by 3 fractions with a once a week schedule. The purpose of this paper is to compare the results between the groups and to clarify the problems in the high-dose-rate group clinically. The local control rate was higher in the high-dose-rate group; however, the complication rate was also higher in this group than in the low-dose-rate group. The dose schedule and the place of rectal dose measurement is discussed. The overall cumulative survival rate was nearly the same in both groups (55% at 5 years), although some difference was noted in each stage. The most common cause of death was distant metastasis outside the pelvis and the second most common was intercurrent disease in Stage IIb and local failure in Stage III.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6841187     DOI: 10.1016/0360-3016(83)90295-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  High dose rate brachytherapy using molds after chemoradiotherapy for oral cavity cancer.

Authors:  Masashi Chatani; Kazuki Tsuboi; Masayuki Yagi; Kanta Fujiwara; Rika Tachimoto; Hideo Yoshioka
Journal:  Jpn J Radiol       Date:  2011-12-14       Impact factor: 2.374

2.  Evolution in brachytherapy.

Authors:  Hugo Marsiglia; Enrique Chajon
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

3.  Intracavitary brachytherapy for carcinoma of the uterine cervix--comparison of HDR (Ir-192) and MDR (Cs-137).

Authors:  Eiichi Tanaka; Osamu Suzuki; Ryoong-Jin Oh; Takashi Takeda; Teruki Teshima; Toshihiko Inoue; Takehiro Inoue
Journal:  Radiat Med       Date:  2006-01

4.  High-dose rate intracavitary irradiation for carcinoma of the uterine cervix. The adverse effect of treatment prolongation.

Authors:  M Chatani; Y Matayoshi; N Masaki; T Inoue
Journal:  Strahlenther Onkol       Date:  1997-07       Impact factor: 3.621

5.  HDR and MDR intracavitary treatment for carcinoma of the uterine cervix. A prospective randomized study.

Authors:  M el-Baradie; T Inoue; T Inoue; S Murayama; J T Tang; H Yamazaki; N Fournier-Bidoz
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

6.  Ultrasound-assisted endocavitary HDR-Ir(192) brachytherapy for unresectable locally advanced uterine cervix carcinoma: retrospective analysis focusing the efficacy and tolerability.

Authors:  Georgios V Koukourakis; Anthoula Miliadou; Ioannis Tsalafoutas; Myrsini G Gkeli; Elisavet Geli; Anastasia Sotiropoulou-Lontou
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

Review 7.  Perpetual role of brachytherapy in organ-sparing treatment for bladder cancer: a historical review.

Authors:  Elzbieta Van der Steen-Banasik; Bernard Oosterveld; Geert Smits; Els Atema; Marion Van Gellekom; Marie Haverkort; Andries Visser
Journal:  J Contemp Brachytherapy       Date:  2020-12-16

8.  High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study.

Authors:  Andrea Vavassori; Giulia Riva; Ruggero Spoto; Roberta Lazzari; Cristiana Fodor; Samantha Dicuonzo; Claudia Maria Francia; Matteo Augugliaro; Giuseppe Facondo; Raffaella Cambria; Stefania Comi; Federica Cattani; Francesca Botta; Vincenzo Bagnardi; Stefania Rizzo; Nicoletta Colombo; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  J Contemp Brachytherapy       Date:  2019-12-08

Review 9.  High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.

Authors:  Ruifeng Liu; XiaoHu Wang; Jin Hui Tian; KeHu Yang; Jun Wang; Lei Jiang; Xiang Yong Hao
Journal:  Cochrane Database Syst Rev       Date:  2014-10-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.